NCT03955263

Brief Summary

The present study is planned to be conducted at a district level women and children's hospital at Nagpur with the following objectives: Objectives: i) To assess the prevalence of asymptomatic malaria infection with all four species of malarial parasites namely P. falciparum, P. malariae, P. ovale and P. vivax during the first/second trimester of pregnancy among women attending the antenatal clinic at a secondary level urban health facility using PCR (polymerase chain reaction) for malaria parasites. ii) To determine the effect of malaria on duration of pregnancy, adverse outcomes and birth outcomes at delivery

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
887

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 28, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 20, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
Last Updated

May 30, 2019

Status Verified

May 1, 2019

Enrollment Period

4 months

First QC Date

May 16, 2019

Last Update Submit

May 28, 2019

Conditions

Keywords

asymptomaticMalariapregnancyprevalenceRT-PCR

Outcome Measures

Primary Outcomes (5)

  • Asymptomatic parasitaemia

    Number of women having asymptomatic malaria which will be detected using a dual-antigen rapid diagnostic kit (RDK), microscopy, and species-specific PCR. PCR for the detection of malaria parasite would be performed at the National Institute for Research in Tribal Health (NIRTH) at Jabalpur, India.

    January 2019 to December 2019

  • Effect of malaria on duration of pregnancy

    Difference in mean gestational age at delivery or end of pregnancy among women with versus those without RT-PCR-confirmed malaria infection during pregnancy.

    January 2019 to December 2019

  • Outcome of the pregnancy

    Number of live births, still birth / miscarriage, elective termination / death after delivery

    January 2019 to December 2019

  • Birth weight

    Difference in mean birth weight among all infants and among term singleton infants born to women with versus those without RT-PCR-confirmed malaria infection during pregnancy

    January 2019 to December 2019

  • Infant Outcome

    Number of episode of Fever till 42 days of infant age among all infants and among term singleton infants born to women with versus those without RT-PCR-confirmed malaria infection during pregnancy

    January 2019 to December 2019

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Pregnant women in their first / second trimester attending Antenatal clinics at district level women and children's hospital at Nagpur

You may qualify if:

  • \- Pregnant woman in first / second trimester of pregnancy

You may not qualify if:

  • Pregnant woman in first / second trimester of pregnancy those do not consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lata Medical Research Foundation

Nagpur, Maharashtra, 440022, India

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Dried Blood Spots

MeSH Terms

Conditions

Malaria

Condition Hierarchy (Ancestors)

Protozoan InfectionsParasitic DiseasesInfectionsMosquito-Borne DiseasesVector Borne Diseases

Study Officials

  • Archana Patel, MD, PhD

    Program Director and CFO, Lata Medical Research Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2019

First Posted

May 20, 2019

Study Start

September 28, 2018

Primary Completion

January 31, 2019

Study Completion

January 31, 2020

Last Updated

May 30, 2019

Record last verified: 2019-05

Locations